Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05893927 · ClinicalTrials.gov registry record · NA
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification, sponsored by The Reading Hospital and Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT05893927: Recruiting NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification, sponsored by The Reading Hospital and Medical Center.
NCT05893927 is a NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification that is actively recruiting participants, run by The Reading Hospital and Medical Center. The registered enrollment target is 65 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05893927, a NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification, is actively recruiting participants, sponsored by The Reading Hospital and Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study. Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study. Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled. Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
Primary Outcome
Blood Test
Conditions Studied
Interventions
- OTHER Diabetes education web site application
Study Locations (1)
Pennsylvania
- Reading Hospital, an affiliate of Tower Health - West Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05893927 shows while recruiting
NCT05893927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Diabetes education web site application is the first listed.
NCT05893927 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05893927 about?
NCT05893927 is a clinical study titled "Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes". The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educatio...
What is the current status of trial NCT05893927?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-02-15. Estimated completion is 2026-09-30.
What conditions does trial NCT05893927 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Lifestyle Modification, Diabetes Education.
What interventions are being tested in trial NCT05893927?
The interventions under investigation include: Diabetes education web site application (OTHER).
Who is sponsoring clinical trial NCT05893927?
This trial is sponsored by The Reading Hospital and Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05893927 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05893927's enrollment target sits among peer trials
65 235th of 348 higher than 114 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI